1. 4-((4-chlorophenyl)methyl)-2- (hexahydro-1-methyl-1h-azepin-4-yl)-1(2h)- Phthalazinone Hcl
2. 4-(p-chlorobenzyl)-2-(n-methylperhydroazepinyl-(4))-1-(2h)-phthalazinone
3. A 5610
4. A-5610
5. Afluon
6. Allergodil
7. Astelin
8. Azelastine
9. Azeptin
10. Corifina
11. Loxin
12. Optilast
13. Optivar
14. Rhinolast
15. Vividrin Akut Azelastin
1. Azelastine Hcl
2. 79307-93-0
3. Optivar
4. Astelin
5. Allergodil
6. Rhinolast
7. Astepro
8. Azeptin
9. Azelastine (hydrochloride)
10. 37932-96-0
11. W-2979m
12. 4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2h)-one Hydrochloride
13. A-5610
14. E-0659
15. Optilast
16. 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride
17. Chebi:2951
18. 0l591qr10i
19. 4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)-1(2h)-phthalazinone Monohydrochloride
20. Ncgc00095173-01
21. Dsstox_cid_25945
22. Dsstox_rid_81243
23. Dsstox_gsid_45945
24. 1(2h)-phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)-, Monohydrochloride
25. 4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1h-azepin-4-yl)phthalazin-1(2h)-one Hydrochloride
26. Corifina
27. Optilas
28. (r)-azelastine Hcl
29. (s)-azelastine Hcl
30. 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)phthalazin-1(2h)-one Hydrochloride
31. Smr000469183
32. Cas-79307-93-0
33. Radethazin
34. Zalastine
35. Azep
36. Sr-01000762975
37. A 5610
38. Astelin (tn)
39. Einecs 253-720-4
40. Azelastine Hydrochloride [usan:jan]
41. Mfcd00242783
42. Astepro Allergy
43. Cpd000469183
44. Schembl36770
45. Mls001401427
46. Mls006010756
47. Spectrum1505340
48. Unii-0l591qr10i
49. Azelastine Hydrochloride- Bio-x
50. Chembl1200809
51. Dtxsid2045945
52. Azelastine Hydrochloride (astelin)
53. Bcpp000358
54. Hms1922f04
55. Pharmakon1600-01505340
56. Bcp23404
57. Hy-b0462
58. Tox21_111469
59. Azelastine Hydrochloride [mi]
60. Ccg-40046
61. Nsc758971
62. Azelastine Hydrochloride (jp17/usp)
63. Azelastine Hydrochloride [jan]
64. Akos015895420
65. Tox21_111469_1
66. Ac-5498
67. Azelastine Hydrochloride [usan]
68. Bcp9000369
69. Ccg-100841
70. Nc00091
71. W- 979m
72. Azelastine Hydrochloride [mart.]
73. Azelastine Hydrochloride [vandf]
74. Azelastine Hydrochloride [usp-rs]
75. Azelastine Hydrochloride [who-dd]
76. Ncgc00095173-02
77. Ncgc00177979-05
78. Allergodil Pound>>azelastine Hydrochloride
79. As-14079
80. Ba164232
81. Azelastine Hydrochloride, >=98% (hplc)
82. Bcp0726000233
83. Ft-0662380
84. Ft-0662381
85. S2552
86. Sw197471-3
87. Azelastine Hydrochloride [orange Book]
88. Azelastine Hydrochloride [ep Monograph]
89. Azelastine Hydrochloride [usp Monograph]
90. C76537
91. D00659
92. Dymista Component Azelastine Hydrochloride
93. 307a930
94. Azelastine Hydrochloride Component Of Dymista
95. Sr-01000762975-4
96. Q27105897
97. Azelastine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
98. 4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)-1-phthalazinone Hydrochloride
99. Azelastine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
100. 4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2h)-onehydrochloride
101. 4-[(4-chlorophenyl)methyl]-2-(1-methyl-4-azepanyl)phthalazin-1-one Hydrochloride
102. Azelastine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
103. Azelastine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 418.4 g/mol |
|---|---|
| Molecular Formula | C22H25Cl2N3O |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 417.1374678 g/mol |
| Monoisotopic Mass | 417.1374678 g/mol |
| Topological Polar Surface Area | 35.9 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 558 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 8 | |
|---|---|
| Drug Name | Astelin |
| PubMed Health | Azelastine (Into the nose) |
| Drug Classes | Nasal Agent |
| Drug Label | Astelin (azelastine hydrochloride) Nasal Spray, 137 micrograms (mcg), is an antihistamine formulated as a metered-spray solution for intranasal administration. Azelastine hydrochloride occurs as a white, almost odorless, crystalline powder with a b... |
| Active Ingredient | Azelastine hydrochloride |
| Dosage Form | Spray, metered |
| Route | Nasal |
| Strength | eq 0.125mg base/spray |
| Market Status | Prescription |
| Company | Meda Pharms |
| 2 of 8 | |
|---|---|
| Drug Name | Astepro |
| Drug Label | ASTEPRO (azelastine hydrochloride) Nasal Spray 0.1%, 137 micrograms (mcg), is an antihistamine formulated as a metered-spray solution for intranasal administration. ASTEPRO (azelastine hydrochloride) Nasal Spray 0.15%, 205.5 micrograms (mcg), is form... |
| Active Ingredient | Azelastine hydrochloride |
| Dosage Form | Spray, metered |
| Route | Nasal |
| Strength | eq 0.1876mg base/spray |
| Market Status | Prescription |
| Company | Meda Pharms |
| 3 of 8 | |
|---|---|
| Drug Name | Azelastine hydrochloride |
| Drug Label | ASTEPRO (azelastine hydrochloride) Nasal Spray 0.1%, 137 micrograms (mcg), is an antihistamine formulated as a metered-spray solution for intranasal administration. ASTEPRO (azelastine hydrochloride) Nasal Spray 0.15%, 205.5 micrograms (mcg), is form... |
| Active Ingredient | Azelastine hydrochloride |
| Dosage Form | Solution/drops; Spray, metered |
| Route | Nasal; Ophthalmic |
| Strength | 0.05%; eq 0.125mg base/spray; eq 0.1876mg base/spray |
| Market Status | Prescription |
| Company | Alcon Pharma; Apotex; Sun Pharma Global; Perrigo Israel |
| 4 of 8 | |
|---|---|
| Drug Name | Optivar |
| PubMed Health | Azelastine |
| Drug Classes | Nasal Agent, Ophthalmologic Agent |
| Drug Label | OPTIVAR (azelastine hydrochloride ophthalmic solution), 0.05% is a sterile ophthalmic solution containing azelastine hydrochloride, a relatively selective H1-receptor antagonist for topical administration to the eyes. Azelastine hydrochloride is a... |
| Active Ingredient | Azelastine hydrochloride |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | 0.05% |
| Market Status | Prescription |
| Company | Meda Pharms |
| 5 of 8 | |
|---|---|
| Drug Name | Astelin |
| PubMed Health | Azelastine (Into the nose) |
| Drug Classes | Nasal Agent |
| Drug Label | Astelin (azelastine hydrochloride) Nasal Spray, 137 micrograms (mcg), is an antihistamine formulated as a metered-spray solution for intranasal administration. Azelastine hydrochloride occurs as a white, almost odorless, crystalline powder with a b... |
| Active Ingredient | Azelastine hydrochloride |
| Dosage Form | Spray, metered |
| Route | Nasal |
| Strength | eq 0.125mg base/spray |
| Market Status | Prescription |
| Company | Meda Pharms |
| 6 of 8 | |
|---|---|
| Drug Name | Astepro |
| Drug Label | ASTEPRO (azelastine hydrochloride) Nasal Spray 0.1%, 137 micrograms (mcg), is an antihistamine formulated as a metered-spray solution for intranasal administration. ASTEPRO (azelastine hydrochloride) Nasal Spray 0.15%, 205.5 micrograms (mcg), is form... |
| Active Ingredient | Azelastine hydrochloride |
| Dosage Form | Spray, metered |
| Route | Nasal |
| Strength | eq 0.1876mg base/spray |
| Market Status | Prescription |
| Company | Meda Pharms |
| 7 of 8 | |
|---|---|
| Drug Name | Azelastine hydrochloride |
| Drug Label | ASTEPRO (azelastine hydrochloride) Nasal Spray 0.1%, 137 micrograms (mcg), is an antihistamine formulated as a metered-spray solution for intranasal administration. ASTEPRO (azelastine hydrochloride) Nasal Spray 0.15%, 205.5 micrograms (mcg), is form... |
| Active Ingredient | Azelastine hydrochloride |
| Dosage Form | Solution/drops; Spray, metered |
| Route | Nasal; Ophthalmic |
| Strength | 0.05%; eq 0.125mg base/spray; eq 0.1876mg base/spray |
| Market Status | Prescription |
| Company | Alcon Pharma; Apotex; Sun Pharma Global; Perrigo Israel |
| 8 of 8 | |
|---|---|
| Drug Name | Optivar |
| PubMed Health | Azelastine |
| Drug Classes | Nasal Agent, Ophthalmologic Agent |
| Drug Label | OPTIVAR (azelastine hydrochloride ophthalmic solution), 0.05% is a sterile ophthalmic solution containing azelastine hydrochloride, a relatively selective H1-receptor antagonist for topical administration to the eyes. Azelastine hydrochloride is a... |
| Active Ingredient | Azelastine hydrochloride |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | 0.05% |
| Market Status | Prescription |
| Company | Meda Pharms |
Histamine H1 Antagonists, Non-Sedating
A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Lipoxygenase Inhibitors
Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)
LOOKING FOR A SUPPLIER?
